Mon, December 19, 2022

Serge Belanger Initiated (VRDN) at Strong Buy and Held Target at $45 on, Dec 19th, 2022

Serge Belanger of Needham, Initiated "Viridian Therapeutics, Inc." (VRDN) at Strong Buy and Held Target at $45 on, Dec 19th, 2022.

Serge has made no other calls on VRDN in the last 4 months.



There are 3 other peers that have a rating on VRDN. Out of the 3 peers that are also analyzing VRDN, 0 agree with Serge's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Serge


  • Tiago Fauth of "Credit Suisse" Initiated at Buy and Held Target at $51 on, Friday, December 16th, 2022
  • Douglas Tsao of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $35 on, Thursday, December 1st, 2022
  • Jason Butler of "JMP Securities" Maintained at Buy with Decreased Target to $46 on, Tuesday, November 15th, 2022